LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

Conditions:   2019 Novel Coronavirus Disease;   2019 Novel Coronavirus Infection;   2019-nCoV Disease;   2019-nCoV Infection;   COVID-19 Pandemic;   COVID-19 Virus Disease;   COVID-19 Virus Infection;   Covid19;   Coronavirus Disease 2019;   SARS-CoV-2 Infection;   SARS-CoV-2 Acute  Respiratory Disease;   COVID-19 Interventions:   Drug: Famotidine;   Drug: Celecoxib;   Other: Placebo Sponsors:   Leidos Life Sciences;   United States Department of Defense Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials